Cargando…

Identification S100A9 as a potential biomarker in neuroblastoma

BACKGROUND: More than half of Neuroblastoma (NB) patients presented with distant metastases and the relapse of metastatic patients was up to 90%. It is urgent to explore a biomarker that could facilitate the prediction of metastasis in NB patients. METHODS AND RESULTS: In the present study, we syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xian, Xue, Yukun, Feng, Jiao, Tian, Qingwu, Zhang, Yunyuan, Wang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604885/ https://www.ncbi.nlm.nih.gov/pubmed/34689294 http://dx.doi.org/10.1007/s11033-021-06783-2

Ejemplares similares

Investigation of the role of the miR17-92 cluster in BMP9-induced osteoblast lineage commitment
por: Zhang, Yunyuan, et al.
Publicado: (2021)

Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis
por: Zhang, Yunyuan, et al.
Publicado: (2022)

Identification of S100A9 as a Potential Inflammation-Related Biomarker for Radiation-Induced Lung Injury
por: Liu, Youyi, et al.
Publicado: (2023)

S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway
por: Duan, Liang, et al.
Publicado: (2013)

Correction: S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway
por: Duan, Liang, et al.
Publicado: (2013)

Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
por: Müller, Irene, et al.
Publicado: (2020)

The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis
por: Song, Junying, et al.
Publicado: (2019)

HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells
por: Duan, Liang, et al.
Publicado: (2018)

Identification of Potential Prognostic Genes for Neuroblastoma
por: Zhong, Xiaodan, et al.
Publicado: (2018)

The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis
por: Bai, Xue, et al.
Publicado: (2022)

Identification of lncRNAs Associated With Neuroblastoma in Cross-Sectional Databases: Potential Biomarkers
por: Prajapati, Bharat, et al.
Publicado: (2019)

S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway
por: Wu, Rui, et al.
Publicado: (2023)

Identification of novel neuroblastoma biomarkers in urine samples
por: Yokota, Kazuki, et al.
Publicado: (2021)

The Significance of Serum S100A9 and TNC Levels as Biomarkers in Colorectal Cancer
por: Zhou, Minze, et al.
Publicado: (2019)

Computational Identification of Gene Networks as a Biomarker of Neuroblastoma Risk
por: Sun, Lidan, et al.
Publicado: (2020)

Bioinformatic Identification of Neuroblastoma Microenvironment-Associated Biomarkers with Prognostic Value
por: Wang, Yi, et al.
Publicado: (2020)

Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity
por: Vogl, Thomas, et al.
Publicado: (2014)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma
por: Arora, Anjali, et al.
Publicado: (2019)

S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
por: Liu, Xiaolin, et al.
Publicado: (2015)

bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma
por: Song, Jingjing, et al.
Publicado: (2022)

Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach
por: Obry, Antoine, et al.
Publicado: (2014)

Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: Results from a proteomic study integrated with bioinformatics analysis
por: ZHANG, LIMIN, et al.
Publicado: (2015)

GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma
por: Luo, Tengling, et al.
Publicado: (2022)

Prognostic Value of microRNA-9 in Various Cancers: a Meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2016)

Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma
por: Huang, Chun-Hao, et al.
Publicado: (2015)

The Gene Expression Analysis of Blood Reveals S100A11 and AQP9 as Potential Biomarkers of Infective Endocarditis
por: Thuny, Franck, et al.
Publicado: (2012)

Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2018)

S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma
por: Quoc, Quang Luu, et al.
Publicado: (2021)

Integrated analysis of DNA methylation and gene expression profiles identified S100A9 as a potential biomarker in ulcerative colitis
por: Su, Shasha, et al.
Publicado: (2020)

Circulating S100A8/A9 is potentially a biomarker that could reflect the severity of experimental colitis in rats
por: Okada, Kohki, et al.
Publicado: (2020)

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
por: Yagyu, Shigeki, et al.
Publicado: (2016)

S100A8 and S100A9, biomarkers of SARS-Cov2-infected patients, suppress HIV replication in primary macrophages
por: Oguariri, Raphael M., et al.
Publicado: (2021)

Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma
por: Zheng, Chen, et al.
Publicado: (2020)

S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12)
por: Cerón, José Joaquín, et al.
Publicado: (2023)

The top 100 most impactful articles and recent trends in nasopharyngeal carcinoma from 1970 to 2018: a bibliometric analysis
por: Wu, QingWu, et al.
Publicado: (2020)

Prediction of crucial epigenetically-associated, differentially expressed genes by integrated bioinformatics analysis and the identification of S100A9 as a novel biomarker in psoriasis
por: Wang, Xin, et al.
Publicado: (2020)

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
por: Hansson, Claes, et al.
Publicado: (2014)

Identification of S100A8 as a common diagnostic biomarkers and exploring potential pathogenesis for osteoarthritis and metabolic syndrome
por: Huang, Xu, et al.
Publicado: (2023)

S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis
por: Wang, Ge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3nr8k39u6fhc3u5nhj1qbc7v9